This study is not yet accepting patients
Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)
Summary
- Eligibility
- for people ages 1 month and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Dates
- study startedestimated completion
- Principal Investigator
- by Kieran O'BrienTom Lietman, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Lead Scientists at UCSF
- Kieran O'Brien
- Tom Lietman, MD
Professor, Proctor Foundation, Chancellor/EVC/FAS. Authored (or co-authored) 416 research publications
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT05288023
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- Expecting 250000 study participants
- Last Updated